Table 2.
Survey | Groupa | Baseline | 6 months |
12 months |
|||||
---|---|---|---|---|---|---|---|---|---|
n | 6 months | Difference | P-valueb | n | 12 months | Difference | |||
SF-12 mental | Cryoballoon | 47.1 ± 10.3 | 258 | 51.1 ± 8.9 | 4.0 ± 9.8 | <0.01 | 236 | 51.2 ± 9.4 | 3.7 ± 10.6 |
RFC | 48.9 ± 9.8 | 267 | 50.8 ± 8.8 | 1.9 ± 9.9 | <0.01 | 230 | 50.7 ± 9.2 | 1.6 ± 10.8 | |
SF-12 physical | Cryoballoon | 43.7 ± 9.1 | 258 | 47.0 ± 9.1 | 3.2 ± 8.2 | <0.01 | 236 | 47.0 ± 9.2 | 3.0 ± 8.7 |
RFC | 44.5 ± 9.5 | 267 | 47.6 ± 8.6 | 3.1 ± 8.6 | <0.01 | 230 | 47.8 ± 8.4 | 3.3 ± 8.7 | |
EQ-5D-3L | Cryoballoon | 0.85 ± 0.14 | 274 | 0.89 ± 0.13 | 0.03 ± 0.14 | <0.01 | 257 | 0.88 ± 0.13 | 0.03 ± 0.14 |
RFC | 0.87 ± 0.12 | 287 | 0.88 ± 0.14 | 0.02 ± 0.14 | 0.03 | 254 | 0.88 ± 0.13 | 0.01 ± 0.14 |
aA linear mixed model was utilized to compare groups across all study visits. No differences were observed between arms in quality-of-life metrics.
b t-Test, change from baseline to 6 months.